Exam Details
Subject | pharmacotherapeutics – i | |
Paper | ||
Exam / Course | pharm d (6–ydc) | |
Department | ||
Organization | G. Pulla Reddy College Of Pharmacy | |
Position | ||
Exam Date | August, 2016 | |
City, State | telangana, hyderabad |
Question Paper
FACULTY OF PHARMACY
Pharm. D II-Year YDC) (Main Backlog) Examination, August 2016
Subject Pharmacotherapeutics I
Time 3 Hours Max. Marks: 70
Note: Answer all questions from Part A and answer any five questions from Part-B.
PART A (10 x 2 20 Marks)
1 Define SV Tachycardia Ventricular Fibrillations
2 What is the role of incretins in Diabetes Mellitus?
3 Write briefly about rational drug use.
4 What are Inflammatory mediatros?
5 What is Framingham Risk Assessment scale?
6 Define Teratogenicity with two examples.
7 Define HbA1C, along with the normal value in diabetics and pre diabetics.
8 What are the complications of Hormone replacement therapy?
9 Categorize Acute Coronary Syndrome.
10 Define FEV1 and Tidal volume.
PART B x 10 50 Marks)
11 Write a note on Pathophysiology and Pharmacological management of Congestive Heart
Failure.
12 What is the role of Cortcosteroids in treating pulmonary disorders?
Write a note on Viral Conjunctivitis.
13 Write a brief note on management of asthma.
Emergency contraception.
14 Discuss the etiopathogenesis, risk factors of Hypertension and its management.
15 Discuss Pharmacological and non pharmacological management of Dyslipidemia.
16 Write notes on
Prescribing guidelines of Paediatrics
Myxoedema coma
17 Write a note on the role of Bisphosphonates in the treatment of osteoporosis
along with its administration guidelines.
Write the place in therapy of the various Sulphonyl ureas and DPP4 inhibitors.
18 Write in detail about Essential Drug concept.
Pharm. D II-Year YDC) (Main Backlog) Examination, August 2016
Subject Pharmacotherapeutics I
Time 3 Hours Max. Marks: 70
Note: Answer all questions from Part A and answer any five questions from Part-B.
PART A (10 x 2 20 Marks)
1 Define SV Tachycardia Ventricular Fibrillations
2 What is the role of incretins in Diabetes Mellitus?
3 Write briefly about rational drug use.
4 What are Inflammatory mediatros?
5 What is Framingham Risk Assessment scale?
6 Define Teratogenicity with two examples.
7 Define HbA1C, along with the normal value in diabetics and pre diabetics.
8 What are the complications of Hormone replacement therapy?
9 Categorize Acute Coronary Syndrome.
10 Define FEV1 and Tidal volume.
PART B x 10 50 Marks)
11 Write a note on Pathophysiology and Pharmacological management of Congestive Heart
Failure.
12 What is the role of Cortcosteroids in treating pulmonary disorders?
Write a note on Viral Conjunctivitis.
13 Write a brief note on management of asthma.
Emergency contraception.
14 Discuss the etiopathogenesis, risk factors of Hypertension and its management.
15 Discuss Pharmacological and non pharmacological management of Dyslipidemia.
16 Write notes on
Prescribing guidelines of Paediatrics
Myxoedema coma
17 Write a note on the role of Bisphosphonates in the treatment of osteoporosis
along with its administration guidelines.
Write the place in therapy of the various Sulphonyl ureas and DPP4 inhibitors.
18 Write in detail about Essential Drug concept.
Other Question Papers
Subjects
- biology
- biopharmaceutics & pharmacokinetics
- biostatistics & research methodology
- clinical & pharmacokinetics pharmacotherapeutic drug monitoring
- clinical pharmacokinetics and pharmacotherapeutic drug monitoring
- clinical pharmacy
- clinical research
- clinical toxicology
- community pharmacy
- hospital pharmacy
- human anatomy and physiology
- medicinal biochemistry
- medicinal chemistry
- pathophysiology
- pharmaceutical analysis
- pharmaceutical formulations
- pharmaceutical inorganic chemistry
- pharmaceutical jurisprudence
- pharmaceutical microbiology
- pharmaceutical organic chemistry
- pharmaceutics
- pharmacoepidmiology and pharmacoeconomics
- pharmacognosy & phytopharmaceuticals
- pharmacology – i
- pharmacology – ii
- pharmacotherapeutics – i
- pharmacotherapeutics – iii
- pharmacotherapeutics-ii